Latigo Biotherapeutics, Inc.

LTGO

Financials

10-QQuarter ended 06/30/2609/03/26

Disclosures

8-KCurrent report09/03/26 8-KCurrent report08/10/26

Prospectuses and Registrations

S-8Registration of securities for employees08/10/26 424B4Prospectus08/07/26 S-1MEFProspectus / registration08/06/26 S-1/ARegistration statement (amended)08/04/26 S-1/ARegistration statement (amended)08/03/26

Proxies

No matching filings.

Ownership

SC 13GBeneficial ownership10/29/26 SC 13GBeneficial ownership08/18/26 SC 13DBeneficial ownership08/17/26 SC 13GBeneficial ownership08/17/26 SC 13GBeneficial ownership08/13/26

Other

CERTCEO/CFO certification08/06/26 EFFECTRequest for effectiveness08/06/26 8-A12B8-A12B08/04/26 DRS/ADRS/A06/05/26 DRS/ADRS/A05/18/26